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Monoclonal  antibodies  (mAb) ~ directed  against  a  T  lymphocyte membrane 
protein complex having characteristics predicted for the T  lymphocyte antigen 
receptor  have recently been  described.  A  disulfide-linked, heterodimer (alpha 
[~] chain, Mr 41,000  and beta [/3] chain, Mr 39,000)  that appeared to be clone- 
specific was first identified on a  murine T  cell lymphoma and was suggested as a 
candidate for  the  T  cell  receptor  (1).  This  protein  complex  was  more  firmly 
implicated as the putative antigen receptor on the basis of functional studies with 
mAbs against similar proteins on  immunocompetent human T  cell clones and 
murine T  cell hybridomas. These mAbs could be shown either to block cytolytic 
function  or  to  stimulate  proliferation  or  interleukin-2  (IL-2)  production  in  a 
clone-specific manner (2-5). 
Biochemical characterization of the putative T  cell receptor molecules from 
different cell lines by peptide mapping revealed both shared and unique peptides 
(6-8).  Moreover, cDNA clones that may represent  one of the chains of the T 
cell  antigen  receptor  (since  they detect  a  genomic  DNA  rearrangement  in  T 
cells) have been obtained and sequenced.  Their encoded amino acid sequences 
suggest that this chain contains regions analogous to variable and constant regions 
of B cell immunoglobulin (9-11).  In this report we demonstrate that the human 
T  lymphocyte antigen receptors from different cloned cell lines share antigenic 
determinants, some of which can be shown to be on the 0~ (heavy) subunit of the 
complex and none of which appear to be accessible at the cell surface. 
Materials and Methods 
Antibodies.  mAbs used were mAb T40/25, anti-antigen receptor on HPB-MLT and 
HPB-ALL (8); mAb P3, used as a control for nonspecific immunoprecipitation (12); mAb 
UCHT-1, anti-human T3,  kindly given by Dr.  Peter Beverly (13);  mAb T29/33,  anti- 
human T-200 (14); and mAb W6/32, anti-HLA-A,B,C monomorphic determinant (15). 
Anti-gp40,49 is a mouse heteroantiserum prepared by immunizing BALB/c mice with an 
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immunoprecipitate of gp40,49 (known to be a glycoprotein based on lectin binding and 
endoglycosidase sensitivity, unpublished observations). Briefly, 2  X  108 HPB-MLT cells 
were solubilized in  1% Nonidet P-40 (NP-40) and immunoprecipitated with 5 #1 of mAb 
T40/25 ascites. The immune complexes (mAb T40/25-gp40,49) were adsorbed to fixed 
Staphylococcus  aureus  Cowan I  strain (SACI) and injected subcutaneously in phosphate- 
buffered saline (PBS) at multiple sites every 3 wk. 9-15 wk later, mouse heteroantiserum 
(anti-gp40,49) was obtained. 
T Cell Lines and Clones.  HPB-ALL and HPB-MLT are human T  cell leukemia lines 
without known antigen specificity (16).  Immunocompetent T  cell lines and clones were 
generated in vitro from alloantigen-stimulated cultures propagated in conditioned media 
containing IL-2 activity (17). Each T cell line or clone was shown to have antigen specificity 
by cell-mediated cytolysis of target cells or specific proliferation responses to irradiated 
aliogeneic stimulator cells.  The lines chosen for study had non-overlapping specificities. 
4E4 was cloned by limiting dilution (<1 cell/well) with ~3% of wells positive for growth. 
It is a cytolytic T  lymphocyte (CTL) T3+, T8+, T4- functionally allospecific for HLA- 
A2.  The  other  cell  lines  were  derived  from  a  different  responder  and  have  been 
subcultured at 5 cells per well. 2G2 is a T3+, T8+, T4-  CTL line allospecific for HLA- 
B27.4C9 is T3+, T8-, T4+, whereas 1F10 is T3+, 60%T8+, 40%T4+. Both these cell 
lines show moderate cytolytic activity and proliferative responses to different allogeneic 
cells but their specificities are not fully characterized. 
Radiolabeling,  Solubilization,  and  Immunoprecipitation.  Cells  were  t~sI labeled  using 
iactoperoxidase with either exogenously added hydrogen peroxide or glucose oxidase and 
glucose as previously described (18,  19).  Briefly, cells were isolated by Ficoll-hypaque 
centrifugation and were typically >95% viable with trypan blue exclusion. The cells were 
washed three times and  l0 T cells were suspended in  1 ml of PBS, pH 7.4 containing  1 
mM magnesium chloride. For the first procedure,  100 #g of lactoperoxidase (80-100 U] 
mg, Sigma) was added, followed by 1 mCi of carrier free Nal~SI (New England Nuclear). 
Then 20 #1 of a  0.03%  hydrogen peroxide stock solution was added every 3 rain for a 
total of six additions.  This procedure was used for the immunoprecipitations shown in 
Figs.  1 and 3. For the second technique, exogenous hydrogen peroxide was omitted and 
generated endogenously  with  glucose oxidase (0.1  U/ml,  Calbiochem) and  glucose (5 
mM). This procedure was used for the immunoprecipitations shown in Fig.  2.  In both 
cases cells were labeled at room temperature. When viable cells are used, these procedures 
have been shown to selectively label cell surface proteins (18,  19).  Immunoprecipitates 
were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
as previously described (20, 21). 
Fluorescence-activated  Cell Analysis.  One  million HPB-MLT cells,  PBL or 4E4  cells 
were incubated with saturating amounts of specific antibody (mAh T40]25 5 #g]ml, anti- 
gp40,49  antiserum diluted  1:10,  or UCHT-1  ascites diluted  1:100),  washed, and then 
stained with fluorescein isothiocyanate-goat anti-mouse IgG or F(ab)'~ as the second stage 
reagent.  Analysis was performed using a  Los Alamos design  cell  sorter as previously 
described (22). 
FmtmE  1.  SDS-PAGE  analysis (10% acrylamide) ofimmunoprecipitates from l~I-labeled T 
cell lines with mAb T40/25, anti-gp40,49 serum, and mAh W6/32. (A) Even numbered lanes 
were reduced (R) or nonreduced  (N) immunoprecipitates  utilizing mAb T40/25 for HPB- 
ALL cells and anti-gp40,49 for immunocompetent T cell lines 4E4, 4C9, 1F 10, and 2G2. The 
odd-numbered lane immediately preceding each even numbered lane is a control immunopre- 
cipitate, reduced or nonreduced,  utilizing normal mouse serum (NMS). Reduced samples were 
incubated in 2 mM dithiothreitol  (DTT) before boiling in SDS and all samples were incubated 
in an excess (15 raM) iodoacetamide  (IAA) after boiling. (B) Immunoprecipitates  from the 
same cell lines shown in A utilizing mAb P3 (negative controls, lanes 1, 4, 7, 10, and 13), mAb 
T40/25 (anti-receptor  on HPB-ALL, lanes 2,  5, 8,  11, and 14), and mAb W6/32 (positive 
controls, lanes 3, 6, 9, 12, and 15). All samples were reduced in 5% 2-mercaptoethanol. The 
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FIGURE 2.  SDS-PAGE analysis  (10%  acrylamide)  of J~51-1abeled immunoprecipitates  from 
Ficoll-Hypaque separated human  PBL and HPB-MLT lymphoma cells.  Anti-gp40,49 serum 
immunoprecipitates from PBL are shown reduced (R) in lane 2 and nonreduced (N) in lane 8. 
For comparison the anti-gp40,49 immunoprecipitate from HPB-MLT cells is shown in lane 6 
(R). mAb T40/25 did not precipitate a specific band (lanes 3 and 9) from PBL. Nonspecific 
precipitates with NMS are shown in lane 1 (R) and  lane  7 (N).  Positive control precipitates 
from PBL with rnAb UCHT-1 (anti-T3) are shown reduced (lane 4) and nonreduced (lane 10) 
and  for T29/33  (anti-T200)  reduced  lane 5  and  nonreduced  lane  11.  The positions of Mr 
markers are shown to the right ×  10  -s. 
Results 
mAbs against the putative T  cell receptors on human and murine T  cell lines 
that have been reported are all clone-specific, with the exception of one mAb 
that  appeared  to  recognize  2-3%  of peripheral  blood  lymphocytes (23).  To 
investigate whether antibodies against common determinants of the human T 
cell receptor could be obtained, mice were immunized with the putative T  cell 
receptor dimer, gp40,49, isolated by immunoprecipitation from HPB-MLT cells 
with  the  clonotypic mAb  T40/25.  Reactivity of the  antiserum  obtained  was 
investigated in immunoprecipitation studies using a  panel of normal, immuno- 
competent T  cell lines. Mouse anti-gp40,49 serum specifically precipitates labeled 
molecules from each of four different immunocompetent T  cells surface-labeled 
by  the  lactoperoxidase  technique  (Fig.  1A).  Under  reducing conditions,  two 
labeled bands  were isolated  from 4E4,  4C9,  and  2G2  cells,  whereas only one 
labeled band  was obtained  from  1F10  cells.  However, it could be shown that 
each cell line yielded disulfide-linked dimers; the ~ subunit (mr 46,000-49,000) 
and/3 subunit (Mr 40,000-45,000) appeared as a single band (Mr 70,000-85,000) 
under nonreducing conditions. Despite the biochemical similarity of the products 
isolated from the four lines, each was readily distinguished from the others and 
from the complex recognized by mAb T40/25  on HPB-ALL cells (lanes 2 and 
4) by differences in  relative molecular mass.  In  Fig.  1A  the 3  (light) subunits 
appear the most variable in Mr, but on other gels of higher acrylamide percentage 
and on three additional lines the ~ (heavy) subunit was also observed to vary in 
M~. ]'he reactivity of mouse anti-gp40,49  serum can be contrasted with that of 
mAb T40/25,  which did not precipitate the receptor complex from any of the BRENNER  ET  AL.  545 
immunocompetent T cell lines (Fig.  1B). Sequential immunoprecipitation studies 
showed that  mAb T40/25  and anti-gp40,49  serum recognize antigenic deter- 
minants on the same molecules from HPB-ALL cells. In further immunoprecip- 
itations,  anti-gp40,49  did  not  react with  several non-T cells,  including the B 
lymphoblastoid cell lines JY and HOM-2, erythroid leukemia cell line K562, and 
the hystiocytic lymphoma cell line U937. 
The ability of mouse anti-gp40,49 serum to recognize the receptor complex 
on  unstimulated  peripheral  blood  lymphocytes (PBL)  was  also  tested.  Anti- 
gp40,49  serum precipitated three bands from PBL under reducing conditions 
(Fig. 2, lane 2), including a more diffuse a chain than that of HPB-MLT (lane 6) 
and two distinct light chains. The amount of radioactivity precipitated by anti- 
gp40,49 serum from PBL was similar to that associated with the T3 glycoprotein 
precipitated by mAb UCHT-1, suggesting that the antiserum was reacting with 
a significant fraction of T  cell receptor molecules present in the PBL lysate, mAb 
T40/25  did not precipitate detectable amounts of the T  cell receptor complex 
from the PBL lysate (lanes 3 and 9). 
To  determine whether the common antigenic determinant(s) on the T  cell 
receptor complex recognized by anti-gp40,49 serum could be localized to the a 
or ~ subunit of the molecule the following experiment was performed. The T 
cell receptor complex was isolated from the T  cell line 2G2  and the a  and 
subunits dissociated by heating in the presence of SDS and dithiothreitol. After 
alkylation  and  dilution  of the  sample  in  buffer containing  NP-40,  a  second 
immunoprecipitation was carried out with anti-gp40,4O serum. As shown in Fig. 
3 (lanes 3 and 4), the isolated a  (heavy) subunit but not the B (light) subunit was 
still reactive with the antiserum. 
When the reactivity of the anti-gp40,49 serum with PBLs was tested by surface 
binding in fluorescence-activated cell analysis, no specific staining was detected 
(Fig. 4C) (compared to the positive control with anti-T3, Fig. 4D), even though 
>95% of HPB-MLT cells were brightly stained with the antiserum (Fig. 4B) as 
with mAb T40/25  (Fig. 4A). This result with PBL was unanticipated given the 
data  presented  in  Fig.  2,  which  suggested  that  the  anti-gp40,49  serum  was 
capable of precipitating a  substantial fraction of the T  cell receptor molecules 
expressed on  PBL.  It seemed unlikely, therefore, that the explanation for the 
discrepancy between fluorescence staining and immunoprecipitation with PBL 
could be that the anti-gp40,49 serum was only recognizing the antigen receptors 
of a small subpopulation of normal T  cells. To investigate this question further, 
the clonal T  cell line 4E4,  from which the T  cell receptor complex could be 
isolated by immunoprecipitation with anti-gp40,49,  was also subjected to fluo- 
rescence-activated cell analysis.  Essentially no staining of 4E4  cells with  anti- 
gp40, 49 was observed (Fig. 4E) (compared to the positive control with anti-T3, 
Fig.  4F).  These  results  suggest that  the staining of HPB-MLT  cells with  the 
antiserum (Fig. 4B) was due to the fraction of antibodies in the antiserum that 
were clone-specific. 
Discussion 
mAb T40/25 recognizes a disulfide-linked glycoprotein heterodimer (gp40,49) 
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FIC,  UR~  3.  SDS-PAGE  analysis (10% acrylamide) of l~5I-labeled immunocompetent T  cell 
line 2G2 immunoprecipitated with anti-gp40,49 serum before and after separation of the a 
and/3 subunits. Lane I is a NMS negative control. Lane 2 is the reduced immunoprecipitate 
with anti-gp40,49. In lanes 3 and 4 immunoprecipitation was performed after separation of 
the a and/3 subunits. To accomplish this a first precipitation was performed as usual and the 
immunoprecipitate adsorbed to SACI was heated, either at 56°C for  15 min (lane 3) or at 
100 ° for 3 min (lane 4), in 2 mM DTT and 1.5% SDS which separates the subunits as shown 
in lane 2. After heating, the SACI were removed by centrifugation and the supernatants were 
diluted in a fivefold excess of 1%  NP-40, 10 mM Tris saline, and  15 mM IAA. A second 
immunoprecipitation was then performed with anti-gp40,49 and SACI. 
described for the proteins recognized by clonotypic mAb directed against func- 
tional  human and  murine  T  cells  (8).  The gp40,49 was therefore isolated and 
used to immunize mice to obtain a  conventional antiserum.  When analyzed by 
immunoprecipitation  and  SDS-PAGE,  the  anti-gp40,49  serum  was  shown  to 
react with a family of closely related protein complexes on PBL and immunocom- 
petent T  cell  lines  and  clones.  Each of these  complexes was a  disulfide-linked 
dimer  and  shared  the  determinant(s)  recognized  by  anti-gp40,49.  However, 
consistent with  the heterogeneity expected  for T  cell antigen  receptors,  there 
were  differences  in  Mr  of  the  complexes  isolated  from  individual  cell  lines 
exhibiting  different  antigen  specificities.  Taken  together,  these  observations 
suggest that it  is possible to obtain antibodies against common antigenic deter- 
minants of the  putative  human  T  cell  receptor by immunization of mice  with 
gp40,49  isolated  from  HPB-MLT  cells  and  confirms  the  relationship  of this 
protein  complex  to  the  antigen  receptor  on  normal  human  T  cells.  A  rabbit 
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FIGURE 4.  Fluorescence-activated cell analysis of T  cell  lymphoma HPB-MLT,  PBL,  and 
immunocompetent CTL clone 4E4. For each analysis a negative control was obtained (dotted 
profile) utilizing NMS for all frames except A in which the negative control was obtained by 
omission of the FITC second stage reagent. The F1TC-conjugated second antibody used was 
intact goat  anti-mouse  IgG  for  the  analysis on  HPB-MLT  and  4E4  cells and  the  F(ab)~' 
fragment was used so as to minimize background staining on PBL.  The lower threshold for 
positive ceils was arbitrarily set at a  fluorescence intensity of two standard deviations higher 
than that of the mean fluorescence of the control and is indicated in each frame by a vertical 
bar. At this setting, 6.8% of PBL were positive with anti-gp40,49 compared to 6.2% for NMS 
and 71% with mAb UCHT-1. Similarly, 4.8% of clone 4E4 were positive with anti-gp40,49 
compared to 3.5% with NMS and 84% with mAb UCHT-1. 
has recently been obtained that also reacts with the receptors of normal murine 
T  cells (7). 
Co-immunoprecipitation  of the T  cell receptor and  the T3  glycoprotein has 
been reported (24, 25) but was not observed in several recent reports (26, 27) 
or in this study (Figs.  1 and 2).  Differences in the methods of solubilization and 
immunoprecipitation  could account for the variable co-immunoprecipitation  of 
these two protein complexes. 
It was shown that after reduction and alkylation of the protein complex in the 
presence of SDS anti-gp40,49 serum specifically reacts with the isolated a subunit 
obtained from one of the immunocompetent T  cell lines (Fig. 3). The c~ subunit 
of the human receptor must, therefore, express one or more shared determinants 
that are immunogenic  in  the mouse.  Previously, peptide mapping  studies have 
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different antigen specificities share common peptides (6) and similar results have 
been  obtained  in  the  mouse  (8).  It  is  possible  that  the  regions  of homology 
between the 13 subunits of human  T  cell receptors with different antigen  speci- 
ficities are less immunogenic  in  the mouse than  those of the o~ subunits.  Alter- 
natively,  the  lack  of reactivity  of the  anti-gp40,49  serum  with  the  isolated 
subunit of the 2G2 cell line may result from the conditions used to separate the 
two subunits. 
Antibodies  against  the  clonotypic determinants  of the  gp40,49  complex  of 
HPB-MLT cells could be readily detected in the anti-gp40,49  serum by quanti- 
tative fluorescence-activated cell analysis.  However, in contrast to the results of 
the  immunoprecipitation  studies,  antibodies  against  common  determinants  of 
the  human  T  cell  receptor  were  not  detected  by  this  cell  surface  staining 
technique. One possible explanation for this observation is that antibodies against 
clonotypic  determinants  predominate  even  if  mice  are  immunized  with  the 
purified  human  T  cell  receptor  and  that  the  immunoprecipitation  techniques 
detect  the  fraction  of antibodies  directed  against  shared  determinants  more 
efficiently than fluorescence-activated cell analysis. In our experience, however, 
antisera  precipitating  the amounts  of radioactivity associated with  the  surface- 
iodinated  T  cell  receptors  shown  in  Figs.  1 and  2  would be expected  to give 
detectable surface staining.  It,  therefore,  seems  more  likely that  the  common 
determinant(s)  recognized by the anti-gp40,49  serum may not be accessible on 
the cell surface. Such determinants could be shielded from reaction with antibody 
at the cell surface by having an orientation internal to the membrane, or because 
of tertiary folding or interaction with another molecule such as the T3 glycopro- 
tein. 
Assuming  that  the  sequences deduced from  the  cDNA clones are  those  for 
one chain of the T  cell receptor, the structure for that chain appears to have two 
Ig-related domains (presumptively V and C) which are N-terminal and exterior 
to a putative membrane spanning peptide (9,  11).  To account for the apparent 
failure of polyclonal anti-gp40,49  serum to react with  these cell surface shared 
determinants,  one must postulate that  (a) this  human  chain  was poorly immu- 
nogenic  in  the  BALB/c  mouse  under  the  immunization  conditions  or  (b)  the 
genome  encodes a  number  of such  T  cell  receptor  specific V  and  C  regions 
which,  like immunoglobulin  V  and  C  region  isotypes, fail to cross-react either 
immunologically  or  by  DNA  hybridization.  Thus,  the  immunizing  antigen, 
gp40,49, may have been of a different isotype than that found on the T  cell lines 
examined,  and  the  precipitating  antibodies  may  have  been  directed  against 
determinants  not accessible on the surface and present on the other chain.  The 
screening methods previously used to identify T  cell receptor molecules required 
some  form  of cell  surface  binding  whether  radioimmunoassay,  fluorescence 
staining,  stimulation,  or  blocking  of  function  and,  therefore,  would  not  be 
expected to detect the antibodies against the shared determinants described here, 
which are not accessible on the cell surface. This has important practical  impli- 
cations for the screening techniques that  may be necessary to identify mAbs to 
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Summary 
A  mouse antiserum, anti-gp40,49  was obtained by immunizing BALB/c mice 
with the putative T  cell  antigen  receptor isolated from  HPB-MLT cells.  This 
antiserum  reacted  with  peripheral  blood  lymphocyte  (PBL)  and  a  panel  of 
immunocompetent T  cell lines and clones in each case precipitating from lysates 
of cells labeled by surface iodination, a disulfide-linked dimer consisting of an 0~ 
subunit Mr (46,000-49,000)  and a  3 subunit Mr (40,000-45,000).  Variability in 
Mr of the two subunits, particularly of the 3  (light) subunit, was observed when 
the receptors of immunocompetent T  cell lines with different antigen specificities 
were compared. Anti-gp40,49 serum reacted selectively with the a  subunit after 
reduction  and  alkylation  of the  protein  complex.  These  results  confirm  the 
relationship between the gp40,49  protein  complex of HPB-MLT cells and the 
putative  T  cell  antigen  receptor  on  normal  immunocompetent  T  cells  and 
indicate that  the o~ subunit of the human  receptor  expressed  shared determi- 
nant(s) that are immunogenic in the mouse. Some features of the T  cell antigen 
receptor appear  to  be  unusual  in  that even  with a  xenoantiserum against  the 
purified  molecule,  only  antibodies  against  clonotypic  determinants  could  be 
detected at the cell surface by quantitative immunofluorescence analysis. 
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